High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling

Reports that President Trump is poised to sign an executive order to reschedule marijuana from Schedule I to Schedule III sparked a rally in cannabis stocks (Canopy Growth among movers) as investors bet the move would remove IRS Section 280E’s ban on deducting ordinary business expenses. Section 280E has left many U.S. cannabis operators with effective tax rates often exceeding 70%, so rescheduling could materially improve margins and make previously unprofitable businesses viable. Analysts and executives call it a potential game-changer, but caution that Schedule III is not full federal legalization—recreational use would remain illegal at the federal level and state-federal conflicts would persist—while the sector traded at above-average volumes with flows into MSOS and major growers such as TLRY, CGC, ACB, CRON and SNDL as investors await an official White House statement.

Analysis

Reports that President Trump is poised to sign an executive order to reschedule marijuana from Schedule I to Schedule III drove a morning rally in cannabis equities, with Canopy Growth (CGC) specifically noted as climbing and the sector trading on above-average volumes and trending on social media as investors awaited an official White House statement. The move is being treated as speculative market news rather than confirmed policy; market sentiment is moderately positive but contingent on an administration announcement.

Section 280E of the tax code — which the article says has prevented deductible business expenses for Schedule I/II substances and produced effective tax rates often exceeding 70% for U.S. cannabis operators — is the principal financial lever behind the optimism. Rescheduling to Schedule III would, per the article, potentially lift the 280E burden, ease research restrictions and materially improve margins, enabling profitability for some previously unprofitable businesses; Curaleaf’s Boris Jordan called it "an absolute game-changer."

Key caveats in the article are that Schedule III is not full federal legalization, recreational use would remain federally illegal, and state-federal conflicts persist; these legal and implementation uncertainties keep the outcome binary and volatility high. Investors should therefore treat current price moves as event-driven, monitor flows into MSOS and the named growers (TLRY, CGC, ACB, CRON, SNDL), and watch for formal federal guidance before adjusting longer-term positions.

Key Decisions for Investors

• Await an official White House statement before making large directional trades since the report is speculative and policy details will drive durable moves
• If rescheduling is confirmed, consider incrementally increasing exposure to leading producers and the MSOS ETF to capture potential margin improvement from relief of Section 280E
• Size positions conservatively and maintain hedges because Schedule III is not full federal legalization and legal/state-federal conflicts could reverse gains
• Use trading-volume and ETF flow data as near-term indicators of sustained investor commitment and scale entries or exits on confirmed follow-through